The clinical application value of interventional management for recurrent cesarean scar pregnancyaft

来源 :2016第十二届亚太介入放射学大会 | 被引量 : 0次 | 上传用户:lvshuijing
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Objective: To discuss the clinical value of interventional treatment for recurrent cesarean scar pregnancy(CSP)after uterine artery chemoembolism(UACE),and to report 2 patients who were successfully treated with UACE combining dilatation and curettage.
其他文献
Objective: To investigate the clinical efficacy of retrograde catheter directed thrombolysis combined with trans-dorsalis pedis vein anterograde thrombolysis therapy(two-way combination thrombolysis t
Purpose: To examine the feasibility of catheter-directed thrombolysis(CDT)using continuous infusion of lowdose urokinase in combination with low molecular-weight heparin(LMWH)for acute iliofemoral ven
Objective: To evaluate the efficacy and safety of treatment of acute pulmonary embolism(PE)using interventional treatment combined with intravenous thrombolysis.
Objective: To evaluate the efficacy and safety of endovascular interventional techniques in the treatment of visceral artery aneurysms(VAA).Methods: Twenty-three patients with VAAs were enrolled in th
Objective: To evaluate the efficacy and safety of lysis treatment for lower extremity deep venous thrombosis(LEDVT)based on comparison of catheter-directed thrombolysis(CDT)and dorsalis pedis venous t
Purpose: The purpose of this study was to evaluate midterm patency of iliac vein following endovascular treatment for iliac vein compression syndrome(IVCS)with or without deep venous thrombosis(DVT).
Objective: This report evaluates the efficiency and safety of catheter-directed thrombolysis(CDT)using tissue plasminogen activator(tPA)and argatroban for the treatment of IVC filter thrombosis compli
Propose: To compare the safety and efficacy of hepatocellular carcinoma(HCC)with main portal vein tumor thrombus(MPVTT)treated by endovascular brachytherapy(EVBT)or three dimensional conformal radioth
Background: Bronchial artery embolisation(BAE)is increasingly accepted as the standard initial treatment for life-threatening haemoptysis,with immediate haemostasis rates reaching 73-99%.
Objective: To analyze and discuss the clinical efficacy and safety of bronchial artery embolization(BAE)treatment of acute massive hemopthsis.